Population pharmacokinetics of amikacin at birth and interindividual variability in renal maturation

European Journal of Clinical Pharmacology

Volumn 57, Issue 5-6, 2001, Pages 499-504

  Arildsson, M ^a   Asker, C L ^a   Salerud, E G ^a   Stromberg T ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Amikacin; Maturation; Neonate; Population pharmacokinetics

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE DERIVATIVE; GENTAMICIN;

ARTICLE; BAYES THEOREM; BIRTH; BODY WEIGHT; CONTROLLED STUDY; DENSITY; DRUG ELIMINATION; GENETIC VARIABILITY; GESTATIONAL AGE; HUMAN; KIDNEY DEVELOPMENT; MOLECULAR EVOLUTION; NEWBORN; POPULATION; POSTNATAL GROWTH; PRIORITY JOURNAL; PROBABILITY; STANDARD; BIRTH WEIGHT; DRUG DISTRIBUTION; DRUG EFFICACY; GRAM NEGATIVE SEPSIS; MAJOR CLINICAL STUDY;

AGE FACTORS; AMIKACIN; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BODY WEIGHT; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; KIDNEY; METABOLIC CLEARANCE RATE; MODELS, BIOLOGICAL; STATISTICS, NONPARAMETRIC;

EID: 85017265712     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280100355     Document Type: Article

References (32)

1. Chemoprophylaxis for group B Streptococcus transmission in neonates
2. Antimicrobial therapy for pediatric patients
3. Group B streptococcal infections
4. Optimizing aminoglycoside therapy for nosocomial pneumonia caused by gram-negative bacteria
5. Hearing screening in at-risk neonate cohort
6. Prospective evaluation of the effect of an aminoglycoside dosing dosing regimen on rates of observed nephrotoxicity and ototoxicity
7. Pharmacocinotique/pharmacodynamie clinique des antibiotiques
8. A suggested approach to once-daily aminoglycoside dosing
9. Population pharmacokinetics of amikacin in newborns from three different grades of gestational age
10. Renal function in sick very low birth weight infants. I. Glomerular filtration rate
11. Pharmacokinetics and renal function in preterm infants
12. Influence of intrauterine maturation on the pharmacokinetics of amikacin in the neonatal period
13. Population pharmacokinetics: Theory and practice
14. Non parametric EM algorithms for estimating prior distributions
15. Gentamicin population pharmacokinetic models for low birth weight infants using a new nonparametric method
16. Population pharmacokinetics of gentamicin in neonates using a non linear, mixed-effect model
17. Population kinetics of gentamicin in neonates
18. Determination of population pharmacokinetic parameters for amikacin in neonates using mixed-effect models
19. Once-a-day individualized amikacin dosing for suspected infections at birth based on population pharmacokinetic models
20. Estimating glomerular filtration rate in infants
21. Optimal sampling times for pharmacokinetic experiments
22. Individualizing drug dosage regimens: Roles of population pharmacokinetic and dynamic models, Bayesian fitting, and adaptive control
23. Developmental patterns of renal functional maturation compared in the human neonate
24. Effect of assumptions concerning assay error patterns upon pharmacokinetic parameter values and model behavior
25. Some suggestions for measuring predictive performance
26. Pharmacokinetics of amikacin in neonates
27. Amikacin pharmacokinetics and suggested dosage modifications for the preterm infant
28. Body composition in appropriate and in small for gestational age infants
29. Longitudinal studies on the rate of decline of renal function with age
30. Gentamicin pharmacokinetics in term neonates receiving extracorporeal membrane oxygenation